Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 2 10Phase 3 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Pain 1Neoplasms 1Cardiovascular Diseases 1Arthralgia 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Fatty Acids, Omega-3 × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

NCT01385137 2017-04-07

S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy

SWOG Cancer Research Network

Phase 3 Completed
262 enrolled 11 charts
Breast

Breast Neoplasms, Pain, Arthralgia

NCT02816125 2016-10-26

Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women

University of Guelph

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡